Target ALS Partners with ZEPHYRx to Enhance Global ALS Research Through Data Integration
NEW YORK, Oct. 23, 2024 /PRNewswire/ -- Target ALS, a leading organization dedicated to breaking down barriers to accelerate amyotrophic lateral sclerosis (ALS) research to find effective treatments, today announced